Nautilus Biotechnology Inc
(NAUT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 11-1993 | 08-1993 | 02-1993 | 02-1992 | |
| Cash Flows From Operating Activities | ||||
| Net Income | N/A | N/A | 10,488 | 7,489 |
| Depreciation Amortization | N/A | N/A | 1,769 | 1,545 |
| Other Working Capital | N/A | N/A | -15,396 | -5,234 |
| Other Operating Activity | 0 | 0 | 408 | 1,797 |
| Operating Cash Flow | $N/A | $N/A | $-2,731 | $5,598 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | N/A | N/A | -1,850 | -1,178 |
| Other Investing Activity | 0 | 0 | -319 | -323 |
| Investing Cash Flow | $N/A | $N/A | $-2,169 | $-1,501 |
| Cash Flows From Financing Activities | ||||
| Other Financing Activity | 0 | 0 | 4,167 | -3,636 |
| Financing Cash Flow | $N/A | $N/A | $4,167 | $-3,636 |
| Beginning Cash Position | N/A | N/A | 1,584 | 1,123 |
| End Cash Position | N/A | N/A | 851 | 1,584 |
| Net Cash Flow | $N/A | $N/A | $-734 | $461 |
| Free Cash Flow | ||||
| Operating Cash Flow | N/A | N/A | -2,731 | 5,598 |
| Free Cash Flow | 0 | 0 | -2,731 | 5,598 |